News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Penumbra, Inc. Enrolls First Patients In PULSE Clinical Trial To Evaluate A Fully Retrievable, Dense Mesh Temporary Stent For Immediate Flow Restoration In Interventional Acute Ischemic Stroke Treatment



11/1/2010 12:22:56 PM

ALAMEDA, Calif.--(BUSINESS WIRE)--The Stroke Teams at the University Hospital Dresden in Dresden, Germany, and the University Hospital Göttingen in Göttingen, Germany, have enrolled the first patients in an international clinical trial to assess the safety and effectiveness of aspiration with the Penumbra System® in conjunction with the Pulse™ flow restoration device. Following on the demonstrated safety and marked effectiveness of the Penumbra System, the PULSE trial aims to demonstrate the performance of an additional adjunctive mode of immediate flow restoration using a temporary stent.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES